{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:43:38Z","timestamp":1788486218863,"version":"build-2803163510"},"reference-count":65,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":10665,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1982,11,12]]},"abstract":"<jats:p>Piperacillin sodium is a beta lactam antibiotic with a broad range of antibacterial activity that includes gram\u2010negative bacilli, gram\u2010positive cocci (except penicillinase\u2010producing <jats:italic>S. aureus<\/jats:italic>) and anaerobic pathogens such as <jats:italic>Clostridium difficile<\/jats:italic>, and <jats:italic>Bacteroides fragilis<\/jats:italic>. Piperacillin inhibits many of the members of the Enterobacteriaceae, including Klebsiella sp and Pseudomonas, at lower concentrations than required for carbenicillin and ticarcillin.<\/jats:p><jats:p>Piperacillin sodium is administered by intramuscular and intravenous injection and is widely distributed throughout body fluids and tissues. Like other newer penicillins, piperacillin is excreted by both renal and biliary mechanisms. The primary route of elimination is by glomerular filtration, which results in high urinary concentrations of the unchanged compound. Piperacillin has been approved for patients with serious infection caused by susceptible strains of specific organisms in intra\u2010abdominal, urinary tract, gynecologic, lower respiratory tract, skin and skin structure, bone and joint, and gonococcal infections and septicemia. As with other penicillins, piperacillin has a low frequency of toxicity. The usual dose of piperacillin in adults with serious infections with normal renal function is 3\u20134 g every 4\u20136 hr as a 20\u201330 min infusion, with a maximum dose of 24 g per day. It is stable in most large volume parenteral solutions. Less serious infections (requiring smaller dosages) may be treated by intramuscular injection; however, no more than 2 g should be given at any one injection site.<\/jats:p><jats:p>Overall, piperacillin has a greater degree of activity than other penicillins. Evidence from prospective studies indicates that piperacillin is a highly effective agent for the treatment of patients with infections caused by susceptible organisms.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1982.tb03202.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T10:16:23Z","timestamp":1450260983000},"page":"287-298","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Piperacillin Sodium: Antibacterial Spectrum, Pharmacokinetics, Clinical Efficacy, and Adverse Reactions"],"prefix":"10.1002","volume":"2","author":[{"given":"Clarence L.","family":"Fortner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"Finley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Schimpff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.12.4.455"},{"key":"e_1_2_1_3_2","volume-title":"Pipracil package insert","author":"Lederle Laboratories, Inc.","year":"1981"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.3.349"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.6.944"},{"key":"e_1_2_1_6_2","first-page":"594","article-title":"New penicillins: piperacillin and hydrazinobenzylpenicillin","volume":"1","author":"Iida K","year":"1978","journal-title":"Curr Chemother."},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.2.257"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1979.tb02031.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.31.1175"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.6.919"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.1.78"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.2.115"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.4.493"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.3.358"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.15.4.540"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(80)80157-0"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000237926"},{"key":"e_1_2_1_18_2","first-page":"599","article-title":"In vitro evaluation of piperacillin sodium, a new broad\u2010spectrum penicillin","volume":"1","author":"Kuck NA","year":"1978","journal-title":"Curr Chemother."},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.4.582"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.4.549"},{"key":"e_1_2_1_21_2","first-page":"200","article-title":"In vitro activity of piperacillin against aerobic bacteria","volume":"23","author":"Roy I","year":"1978","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.30.1107"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.5.625"},{"key":"e_1_2_1_24_2","first-page":"158","article-title":"Antibacterial activity of piperacillin against gram\u2010negative bacteria","volume":"26","author":"Gentry LO","year":"1979","journal-title":"Curr Ther Res."},{"key":"e_1_2_1_25_2","unstructured":"MoodyMR YoungV SchimpffSC.Synergistic activity of piperacillin\u2010moxalactam\u2010amikacin combinations (abstract). 20th Interscience Conference on Antimicrobial Agents and Chemotherapy New Orleans 1980:752."},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.4.634"},{"key":"e_1_2_1_27_2","first-page":"264","article-title":"In vitro study of piperacillin: A new semisynthetic penicillin","volume":"6","author":"Agudelo NO","year":"1979","journal-title":"Investigacion Medica Internacional."},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01641616"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.6.893"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197926141"},{"key":"e_1_2_1_31_2","volume-title":"Piperacillin \u2014 a review of pharmacokinetic and clinical aspects (abstract)","author":"DeSchepper PJ","year":"1978"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/4.3.255"},{"key":"e_1_2_1_33_2","first-page":"605","article-title":"Pharmacokinetics of piperacillin administered by bolus, infusion, and bolus plus infusion","volume":"1","author":"Evans MAL","year":"1978","journal-title":"Curr Chemother."},{"key":"e_1_2_1_34_2","first-page":"105","article-title":"Pharmacokinetics of piperacillin sodium in man","volume":"5","author":"Morrisoin JA","year":"1979","journal-title":"Drugs Under Experimental and Clinical Research."},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.6.829"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.4.608"},{"key":"e_1_2_1_37_2","unstructured":"ThompsonIB RussoJ RussoMEet al.Piperacillin distribution into fat muscle gallbladder tissue bile and urine in surgical patients (abstract). 21th Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago 1981:401."},{"key":"e_1_2_1_38_2","unstructured":"WhittmannDH SchassanHH.Bone levels tissue\u2010fluid and peritoneal fluid measurements following piperacillin administration (abstract). 20th Interscience Conference on Antimicrobial Agents and Chemotherapy New Orleans 1980:757."},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.4.481"},{"key":"e_1_2_1_40_2","first-page":"307","article-title":"Diffusion of piperacillin into human heart muscle","volume":"1","author":"Adam D","year":"1980","journal-title":"Curr Chemother and Infectious Disease."},{"key":"e_1_2_1_41_2","unstructured":"TunnU AdamD.Piperacillin levels in renal tissue in patients (abstract). 20th Interscience Conference on Antimicrobial Agents and Chemotherapy New Orleans 1980:756."},{"key":"e_1_2_1_42_2","unstructured":"LutzFB MogabgobWJ.Therapeutic efficacy of piperacillin in serious infections in adults (abstract). 18th Interscience Conference on Antimicrobial Agents and Chemotherapy Atlanta 1978:303."},{"key":"e_1_2_1_43_2","first-page":"305","article-title":"Diffusion and pharmacokinetics of piperacillin in prostatic tissue","volume":"1","author":"Tunn U","year":"1980","journal-title":"Curr Chemother Infect Dis."},{"key":"e_1_2_1_44_2","first-page":"285","article-title":"Piperacillin in the treatment of severe infections: clinical evaluation and pharmacokinetics in serum, wound fluid, and subcutaneous tissue","volume":"1","author":"Linglof TO","year":"1980","journal-title":"Curr Chemother Infect Dis."},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.3.450"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.6.788"},{"key":"e_1_2_1_47_2","unstructured":"Hoogkamp\u2010KorstanjeJAA.Treatment of severe neonatal infections with piperacillin with or without gentamicin (abstract). 12th International Congress of Chemotherapy. Florence Italy 1981:567."},{"key":"e_1_2_1_48_2","unstructured":"RubioT WirthF KarotkinE.Pharmacokinetics of piperacillin in newborn infants (abstract). 12th International Congress of Chemotherapy Florence Italy 1981:566."},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.2.268"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.2.309"},{"key":"e_1_2_1_51_2","unstructured":"SweetR RobbieM Ohm\u2010SmithMet al.Comparative study of piperacillin versus cefoxitin in the treatment of female pelvic infections (abstract). 12th International Congress of Chemotherapy Florence Italy 1981:569."},{"key":"e_1_2_1_52_2","unstructured":"LancasterDJ WignallFS KerbsSBJet al.Parenteral piperacillin in the treatment of uncomplicated urethritis due to penicillinase\u2010producing Neisseria gonorrhoeae (abstract). 21st Interscience Conference of Antimicrobial Agents and Chemotherapy Chicago III.1981:406."},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197105132841904"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)91170-7"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(81)90324-7"},{"key":"e_1_2_1_56_2","unstructured":"HewittWL MurphyW WinstonDet al.Comparative efficacy and toxicity of piperacillin\/amikacin versus carbenicillin\/amikacin in granulocytopenic patients (abstract). 20th Interscience Conference on Antimicrob Agents and Chemother. New Orleans.1980:484."},{"key":"e_1_2_1_57_2","unstructured":"DejonghCA JoshiJ NewmanKAet al.Moxalactam plus piperacillin or amikacin: empiric antibiotic therapy for febrile neutropenic cancer patients (abstract). 2nd International Symposium on Infections in the Immunocompromised Host Stirling Scotland 1982."},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90386-1"},{"key":"e_1_2_1_59_2","first-page":"300","article-title":"Complications of the treatment of bacterial infections with piperacillin","volume":"1","author":"Bouza E","year":"1980","journal-title":"Curr Chemother Infect Dis."},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198020050-00001"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.4.532"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-78-5-774"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1159\/000237930"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01640976"},{"key":"e_1_2_1_65_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-3565(25)32538-3","article-title":"Effects of concentration and time upon inactivation of tobrtamycin, gentamicin, netilmicin, and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin","volume":"217","author":"Pickering LK","year":"1981","journal-title":"J Pharmacol Exp Ther."},{"key":"e_1_2_1_66_2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/ajcp\/74.3.316","article-title":"In vitro inactivation of aminoglycosides antibiotic by piperacillin and carbenicillin","volume":"74","author":"Hale DC","year":"1980","journal-title":"Am J Clin Pathol."}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1982.tb03202.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1982.tb03202.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1982.tb03202.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:48:24Z","timestamp":1761047304000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1982.tb03202.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,11,12]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1982,11,12]]}},"alternative-id":["10.1002\/j.1875-9114.1982.tb03202.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1982.tb03202.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,11,12]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}